Posted: April 8, 2022

Ohio Governor Mike DeWine signed Executive Order 2022-05D to suspend the normal rulemaking process to allow the State of Ohio Board of Pharmacy to classify seven benzimidazole-opioids as Schedule I controlled substances pursuant to OAC 4729:9-1-01.02.  For more information please visit the State of Ohio Board of Pharmacy website